InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Lacey David L., 董事. Director active across 1 company, notably Arcus Biosciences, Inc.. In total, 6 disclosures have been recorded. History available since 3 June 2021. The latest transaction was filed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lacey David L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
5,700 股Common StockSEC:0001734422-26-000005:0
13,300 股0Common StockSEC:0001724521-25-000088:0
8,400 股0Common StockSEC:0001724521-24-000115:0
6,800 股0Common StockSEC:0001209191-23-038145:0
4,100 股0Common StockSEC:0001209191-22-037412:0
3,000 股0Common StockSEC:0001209191-21-038623:0
6 条申报中的 6 条
About Lacey David L.
David L. Lacey is a Board Member at Arcus Biosciences, Inc. He plays a key role in overseeing the activities and strategy of the company. Lacey is recognized for his expertise in the biotechnology field.
